Related Experiment Video
Updated: Dec 27, 2025

Artificial Lung Device Priming for In Situ Fiber Bundle Surface Grafting
Published on: March 28, 2025
Aggressive Antithrombin Supplementation Often Not Necessary During Extracorporeal Membrane Oxygenation
Scott D Nei1, Patrick M Wieruszewski, Erica D Wittwer
1Department of Pharmacy, Mayo Clinic, Rochester, Minnesota Department of Pharmacy, Mayo Clinic, Rochester, Minnesota, Multidisciplinary Epidemiology and Translational Research in Intensive Care (METRIC) Group, Mayo Clinic, Rochester, Minnesota Multidisciplinary Epidemiology and Translational Research in Intensive Care (METRIC) Group, Mayo Clinic, Rochester, Minnesota, Department of Anesthesiology and Perioperative Medicine, Mayo Clinic, Rochester, Minnesota, wittwer.erica@mayo.edu.
No abstract available in PubMed .
Related Concept Videos
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Venous Thrombosis III: Interprofessional Care
Extracorporeal Removal of Drugs: Hemoperfusion and Hemofiltration
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy

